{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:47:59Z","timestamp":1773960479748,"version":"3.50.1"},"reference-count":13,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2020,8,31]]},"DOI":"10.5582\/irdr.2020.03064","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T22:05:15Z","timestamp":1596665115000},"page":"137-140","source":"Crossref","is-referenced-by-count":3,"title":["The challenge of managing comorbidities: a case report of primary Sjogren's syndrome in a patient with acute intermittent porphyria"],"prefix":"10.5582","volume":"9","author":[{"given":"Qing","family":"Teng","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuelin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiran","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninglin","family":"Kang","sequence":"additional","affiliation":[{"name":"Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanxiang","family":"Hu","sequence":"additional","affiliation":[{"name":"Geriatrics, First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songyun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Benassi F, Righi E, Cimato P, Parravicini R. Cardiac surgery in patients with acute intermittent porphyria. J Card Surg. 2012; 27:331-4.","DOI":"10.1111\/j.1540-8191.2011.01350.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X.Primary Sjogren syndrome. BMJ. 2012; 344:3821.","DOI":"10.1136\/bmj.e3821"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Floderus Y, Shoolingin-Jordan PM, Harper P. Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene. Clin Genet. 2002; 62:288-697.","DOI":"10.1034\/j.1399-0004.2002.620406.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shen L, He J, Kramer JM, Bunya VY. Sj\u00f6gren&apos;s Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis. J Immunol Res. 2019; 2019:8101503.","DOI":"10.1155\/2019\/8101503"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000; 47:85-118.","DOI":"10.1016\/S0162-3109(00)00188-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bertsias GK, Tektonidou M, Amoura Z, <i>et al.<\/i> Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012; 71:1771-1782.","DOI":"10.1136\/annrheumdis-2012-201940"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lai Q, Luo Z, Wu C, Lai S, Wei H, Li T, Wang Q, Yu Y.Attenuation of cyclosporine A induced nephrotoxicity by schisandrin B through suppression of oxidative stress, apoptosis and autophagy. Int Immunopharmacol. 2017; 52:15-23.","DOI":"10.1016\/j.intimp.2017.08.019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Caires A, Fernandes GS, Leme AM, Castino B, Pessoa EA, Fernandes SM, Fonseca CD, Vattimo MF, Schor N, Borges FT. Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats. Braz J Med Biol Res. 2017; 51:6373.","DOI":"10.1590\/1414-431x20176373"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Logan JK, Wickramaratne Senarath Yapa S, Harinstein L, Saluja B, Mu\u00f1oz M, Sahajwalla C, Neuner R, Seymour S. Drug interaction between febuxostat and thiopurine antimetabolites: a review of the FDA Adverse Event Reporting System and medical literature. Pharmacotherapy. 2020; 40:125-132.","DOI":"10.1002\/phar.2362"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Stoenoiu MS, Aydin S, Tektonidou M, <i>et al.<\/i> Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: Data from the MAINTAIN Nephritis Trial. Nephrol Dial Transplant. 2012; 27:1924-1930.","DOI":"10.1093\/ndt\/gfr553"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mirouse A, Seror R, Vicaut E, <i>et al.<\/i> Arthritis in primary Sj\u00f6gren&apos;s syndrome: characteristics, outcome and treatment from French multicenter retrospective study. Autoimmun Rev. 2019; 18:9-14.","DOI":"10.1016\/j.autrev.2018.06.015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Argyropoulou OD, Tzioufas AG. Common and rare forms of vasculitis associated with Sj\u00f6gren&apos;s syndrome. Curr Opin Rheumatol. 2020; 32:21-28.","DOI":"10.1097\/BOR.0000000000000668"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Leanna MW, Daniel GA. A patient with primary Sjogren&apos;s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: A case-based review. Clin Rheumatol. 2020; 39:1357-136.","DOI":"10.1007\/s10067-019-04886-7"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/9\/3\/9_2020.03064\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T03:37:03Z","timestamp":1599881823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/9\/3\/9_2020.03064\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2020.03064","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,31]]}}}